Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients
Ahmed Samir Abdelhafiz, Mariam A. Fouad, Mohamed M. Sayed‐Ahmed, Mahmoud M. Kamel, Asmaa Ali, Merhan A. Fouda, Mahmoud A. F. Khalil, Ahmed S. Abdel‐Moneim, Lamyaa Kamal
Topics & Concepts
Downregulation and upregulationFOXP3Hypoxia (environmental)BiologyMessenger RNAReal-time polymerase chain reactionImmunologyCoronavirus disease 2019 (COVID-19)BiomarkerProportional hazards modelInternal medicineDiseaseMedicineImmune systemGeneInfectious disease (medical specialty)ChemistryOxygenOrganic chemistryBiochemistryCOVID-19 Clinical Research StudiesInflammasome and immune disordersLong-Term Effects of COVID-19